APA (7th ed.) Citation

Bleher, D., Poxleitner, M., Grotegerd, A., Hihn, O., Kuebler, L., Bowden, G., . . . Herfert, K. (2026). Preclinical evaluation of [18F]fluoroethylresorufin as PET tracer for cerebral amyloid angiopathy. EJNMMI Research, 16(1), 1. https://doi.org/10.1186/s13550-026-01470-4

Chicago Style (17th ed.) Citation

Bleher, Daniel, et al. "Preclinical Evaluation of [18F]fluoroethylresorufin as PET Tracer for Cerebral Amyloid Angiopathy." EJNMMI Research 16, no. 1 (2026): 1. https://doi.org/10.1186/s13550-026-01470-4.

MLA (9th ed.) Citation

Bleher, Daniel, et al. "Preclinical Evaluation of [18F]fluoroethylresorufin as PET Tracer for Cerebral Amyloid Angiopathy." EJNMMI Research, vol. 16, no. 1, 2026, p. 1, https://doi.org/10.1186/s13550-026-01470-4.